Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Acerta Pharma BV
Acerta Pharma BV
Acerta Pharma BV
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
BeOne Medicines
University of California, Irvine
University of Washington
AstraZeneca
Orca Biosystems, Inc.
Dana-Farber Cancer Institute
City of Hope Medical Center
Celgene
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Bristol-Myers Squibb
Acerta Pharma BV